ImmunoINSIGHTS signs contract with leading top 10 global pharmaceutical company to profile biomarkers in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (“CIDP”). March 4, 2022 10:17 am
March 4, 2022 10:17 am
